More evidence for bedside BNP in heart failure assessment
- 31 December 2002
- journal article
- editorial
- Published by Elsevier in International Journal of Cardiology
- Vol. 86 (2-3) , 149-152
- https://doi.org/10.1016/s0167-5273(02)00410-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failureInternational Journal of Cardiology, 2002
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressinCardiovascular Research, 2001
- Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care settingJournal of the American College of Cardiology, 2001
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- The importance and complexity of neurohumeral over-activity in chronic heart failureInternational Journal of Cardiology, 2000
- Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practiceClinical Science, 1999
- Editorials How to use natriuretic peptide levels for diagnosis and prognosisPublished by Oxford University Press (OUP) ,1999
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasisClinical Science, 1992